Semaglutide — Dosing in CKD & Dialysis

Semaglutide (GLP-1 Receptor Agonist): renal dosing adjustments, dialyzability (Not expected to be removed by dialysis: molecular weight 4113.58 g/mol and more than 99% bound to plasma albumin (both labels, sections 11 and 12.3); hemodialysis did not appear to affect semaglutide pharmacokinetics in a

Reviewed by Matt · November 17, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.